[Autoimmune polyglandular disorders in myotonic dystrophy]

Area of Science:

• Genetics and Molecular Biology
• Endocrinology
• Neuromuscular Disorders

Background:

• Myotonic dystrophy type 1 (MD1) is the most prevalent adult-onset muscle disorder, characterized by autosomal dominant inheritance and significant clinical variability.
• Pathophysiology involves mutations in the DMPK gene, disrupting RNA metabolism, mRNA maturation, and translation, impacting skeletal muscle, smooth muscle, and cardiac cells.

Observation:

• The hallmark symptom of MD1 is myotonia, an inability to relax muscles after contraction.
• Endocrine manifestations in MD1 frequently include hypergonadotropic hypogonadism, impaired glucose tolerance with hyperinsulinism, and insulin resistance.
• Thyroid dysfunction, such as autoimmune thyroiditis leading to hypothyroidism or Graves' disease, is also observed, though thyroid function can be normal.

Findings:

• This report details a patient with MD1 presenting with multiple endocrine disorders: hypergonadotropic hypogonadism, autoimmune thyroid disease, hyperinsulinism, and disturbed calcium-phosphorus metabolism.
• Notably, the patient exhibited elevated creatine phosphokinase (CPK) levels, a characteristic of MD, despite minimal muscular complaints.
• The case underscores the importance of observing the temporal progression and specific nature of thyroid abnormalities within the context of MD1.

Implications:

• The study emphasizes the complex interplay between genetic mutations in MD1 and diverse endocrine system dysfunctions.
• It highlights the need for comprehensive endocrine screening in MD1 patients, even in the absence of overt muscular symptoms.
• Understanding these associations can lead to improved diagnostic strategies and patient management for myotonic dystrophy type 1.